The developer known for his outrageous ambition is stepping into the world of cell and gene therapy. But with this new venture, he’ll try to balance purpose and profit, for legacy’s sake.
But these portable hospital rooms invented by a Drexel alum might.
Chimeron Bio’s technology could make a future coronavirus vaccine more accessible to patients and cheaper for companies to produce.
As the city’s hospitals prepare for an influx of coronavirus patients, Philly nurses fear they won’t be able to protect themselves or their loved ones.
A Penn surgeon is the first in the Philadelphia region to offer the Resensation treatment.
Carisma Therapeutics wants to be the first to engineer a macrophage, a parasite-eating white blood cell found in humans, to destroy cancer tumors.
B.PHL’s chief planner, Michelle Histand, says the festival will be bigger and better in 2020. Here’s what you can expect to see.
One expert says the the Federal Trade Commission’s complaint is itself enough to kill the proposed deal.
Move over, Siri and Alexa. WellBe is here to take the virtual assistant market to new heights with at-home healthcare support.
Castle Creek Biosciences is developing several treatments that may provide relief for “Butterfly Children” and others living with rare genetic diseases.
Venatorx Pharmaceuticals is leading the race to develop new antibiotics before the next drug-resistant superbug spreads.
With an innovative curriculum, the partnership offers faster paths to careers in the growing sector.
Ocugen has developed a new platform that could help bring greater attention to underserved areas of ophthalmology.